Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers

Isr Med Assoc J. 2009 Nov;11(11):664-8.

Abstract

Background: It is common practice to use topical antiseptic formulations prior to specific therapy in superficial infections and injuries, but not in corneal bacterial ulcers. There is accumulating evidence proving chlorhexidine gluconate 0.02%, an antiseptic agent, as an effective treatment for infectious keratitis.

Objectives: To investigate the safety and efficacy of chlorhexidine gluconate 0.02% as an adjunct therapy for corneal bacterial ulcers.

Methods: Twenty-six patients with corneal bacterial ulcers were treated with standard empirical antibiotic treatment. The study group was treated with chlorhexidine gluconate 0.02% while controls received placebo for one week. The patients were followed for at least 1 month.

Results: No allergic or toxic reactions were noted. Although a higher baseline severity of ulcers existed in the study group, no differences were found in final vision, scarring extent, or recovery duration.

Conclusions: Chlorhexidine gluconate 0.02% may improve the clinical course of corneal ulcers.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents, Local / therapeutic use*
  • Chlorhexidine / analogs & derivatives*
  • Chlorhexidine / therapeutic use
  • Corneal Ulcer / drug therapy*
  • Corneal Ulcer / microbiology*
  • Corneal Ulcer / pathology
  • Double-Blind Method
  • Drug Therapy, Combination
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Instillation, Drug
  • Israel
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Ophthalmic Solutions
  • chlorhexidine gluconate
  • Chlorhexidine